Atomera Incorporated (NASDAQ:ATOM - Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $7.71 and traded as low as $5.87. Atomera shares last traded at $5.98, with a volume of 228,515 shares.
Atomera Stock Performance
The company has a current ratio of 5.25, a quick ratio of 5.25 and a debt-to-equity ratio of 0.05. The firm has a fifty day moving average price of $7.36 and a 200 day moving average price of $6.34. The firm has a market cap of $173.17 million, a PE ratio of -8.29 and a beta of 1.53.
Atomera (NASDAQ:ATOM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The technology company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Atomera had a negative return on equity of 106.81% and a negative net margin of 13,655.55%.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Atomera in the 3rd quarter valued at about $44,000. XTX Topco Ltd purchased a new stake in Atomera in the 3rd quarter valued at about $76,000. SLT Holdings LLC purchased a new stake in Atomera in the 4th quarter valued at about $116,000. Barclays PLC purchased a new stake in Atomera in the 4th quarter valued at about $116,000. Finally, Brendel Financial Advisors LLC purchased a new stake in Atomera in the 4th quarter valued at about $124,000. Hedge funds and other institutional investors own 30.79% of the company's stock.
Atomera Company Profile
(
Get Free Report)
Atomera Incorporated engages in the developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors.
Further Reading
Before you consider Atomera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atomera wasn't on the list.
While Atomera currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
